Form 8-K · Current Report · Filed 2026-02-17
Kenvue Announces FY 2025 Results and Announces Restructuring Initiative
Kenvue Inc. reported its financial results for the full fiscal year and fourth quarter of 2025, showing a net sales increase of 3.2% and 1.2% organic sales growth in Q4. However, for the full year, net sales decreased by 2.1% and organic sales declined by 2.2%. The company also announced a restructuring initiative expected to result in a net global workforce reduction of approximately 3.5% and pre-tax restructuring expenses of approximately $250 million in 2026. Diluted EPS for Q4 was $0.17, up from $0.15 in the prior year, and full-year diluted EPS was $0.76. Adjusted diluted EPS for Q4 was $0.27 and $1.08 for the full year. The company did not provide forward-looking guidance due to the pending transaction with Kimberly-Clark.
- Filer
- Kenvue Inc. KVUE · NYSE
- Filed
- Accession
- 0001944048-26-000016
- CIK
- 0001944048
- Signal
- Medium impactConsumer Defensive
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$18.70
Next session
+1.0%
Since filing
+2.9%
Latest close
$19.24
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from KVUE reporting the same item, with the next session's move:
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Never miss another KVUE filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.